Global Lower GI Series Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Lower GI Series market report explains the definition, types, applications, major countries, and major players of the Lower GI Series market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Ironwood Pharmaceuticals

    • Purdue Pharma

    • Eisai

    • Novadaq

    • Astrazeneca

    • Cadila Pharmaceuticals

    • Peacehealth

    By Type:

    • Double-Contrast

    • Single-Contrast

    By End-User:

    • Gastroenteritis

    • Colon Polyps

    • Tumor

    • Strictures Crohn's Disease

    • Ulcerative Colitis

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Lower GI Series Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Lower GI Series Outlook to 2028- Original Forecasts

    • 2.2 Lower GI Series Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Lower GI Series Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Lower GI Series Market- Recent Developments

    • 6.1 Lower GI Series Market News and Developments

    • 6.2 Lower GI Series Market Deals Landscape

    7 Lower GI Series Raw Materials and Cost Structure Analysis

    • 7.1 Lower GI Series Key Raw Materials

    • 7.2 Lower GI Series Price Trend of Key Raw Materials

    • 7.3 Lower GI Series Key Suppliers of Raw Materials

    • 7.4 Lower GI Series Market Concentration Rate of Raw Materials

    • 7.5 Lower GI Series Cost Structure Analysis

      • 7.5.1 Lower GI Series Raw Materials Analysis

      • 7.5.2 Lower GI Series Labor Cost Analysis

      • 7.5.3 Lower GI Series Manufacturing Expenses Analysis

    8 Global Lower GI Series Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Lower GI Series Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Lower GI Series Export by Region (Top 10 Countries) (2017-2028)

    9 Global Lower GI Series Market Outlook by Types and Applications to 2022

    • 9.1 Global Lower GI Series Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Double-Contrast Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Single-Contrast Consumption and Growth Rate (2017-2022)

    • 9.2 Global Lower GI Series Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Gastroenteritis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Colon Polyps Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Strictures Crohn's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Lower GI Series Market Analysis and Outlook till 2022

    • 10.1 Global Lower GI Series Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Lower GI Series Consumption (2017-2022)

      • 10.2.2 Canada Lower GI Series Consumption (2017-2022)

      • 10.2.3 Mexico Lower GI Series Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Lower GI Series Consumption (2017-2022)

      • 10.3.2 UK Lower GI Series Consumption (2017-2022)

      • 10.3.3 Spain Lower GI Series Consumption (2017-2022)

      • 10.3.4 Belgium Lower GI Series Consumption (2017-2022)

      • 10.3.5 France Lower GI Series Consumption (2017-2022)

      • 10.3.6 Italy Lower GI Series Consumption (2017-2022)

      • 10.3.7 Denmark Lower GI Series Consumption (2017-2022)

      • 10.3.8 Finland Lower GI Series Consumption (2017-2022)

      • 10.3.9 Norway Lower GI Series Consumption (2017-2022)

      • 10.3.10 Sweden Lower GI Series Consumption (2017-2022)

      • 10.3.11 Poland Lower GI Series Consumption (2017-2022)

      • 10.3.12 Russia Lower GI Series Consumption (2017-2022)

      • 10.3.13 Turkey Lower GI Series Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Lower GI Series Consumption (2017-2022)

      • 10.4.2 Japan Lower GI Series Consumption (2017-2022)

      • 10.4.3 India Lower GI Series Consumption (2017-2022)

      • 10.4.4 South Korea Lower GI Series Consumption (2017-2022)

      • 10.4.5 Pakistan Lower GI Series Consumption (2017-2022)

      • 10.4.6 Bangladesh Lower GI Series Consumption (2017-2022)

      • 10.4.7 Indonesia Lower GI Series Consumption (2017-2022)

      • 10.4.8 Thailand Lower GI Series Consumption (2017-2022)

      • 10.4.9 Singapore Lower GI Series Consumption (2017-2022)

      • 10.4.10 Malaysia Lower GI Series Consumption (2017-2022)

      • 10.4.11 Philippines Lower GI Series Consumption (2017-2022)

      • 10.4.12 Vietnam Lower GI Series Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Lower GI Series Consumption (2017-2022)

      • 10.5.2 Colombia Lower GI Series Consumption (2017-2022)

      • 10.5.3 Chile Lower GI Series Consumption (2017-2022)

      • 10.5.4 Argentina Lower GI Series Consumption (2017-2022)

      • 10.5.5 Venezuela Lower GI Series Consumption (2017-2022)

      • 10.5.6 Peru Lower GI Series Consumption (2017-2022)

      • 10.5.7 Puerto Rico Lower GI Series Consumption (2017-2022)

      • 10.5.8 Ecuador Lower GI Series Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Lower GI Series Consumption (2017-2022)

      • 10.6.2 Kuwait Lower GI Series Consumption (2017-2022)

      • 10.6.3 Oman Lower GI Series Consumption (2017-2022)

      • 10.6.4 Qatar Lower GI Series Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Lower GI Series Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Lower GI Series Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Lower GI Series Consumption (2017-2022)

      • 10.7.2 South Africa Lower GI Series Consumption (2017-2022)

      • 10.7.3 Egypt Lower GI Series Consumption (2017-2022)

      • 10.7.4 Algeria Lower GI Series Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Lower GI Series Consumption (2017-2022)

      • 10.8.2 New Zealand Lower GI Series Consumption (2017-2022)

    11 Global Lower GI Series Competitive Analysis

    • 11.1 Ironwood Pharmaceuticals

      • 11.1.1 Ironwood Pharmaceuticals Company Details

      • 11.1.2 Ironwood Pharmaceuticals Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Ironwood Pharmaceuticals Lower GI Series Main Business and Markets Served

      • 11.1.4 Ironwood Pharmaceuticals Lower GI Series Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Purdue Pharma

      • 11.2.1 Purdue Pharma Company Details

      • 11.2.2 Purdue Pharma Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Purdue Pharma Lower GI Series Main Business and Markets Served

      • 11.2.4 Purdue Pharma Lower GI Series Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Eisai

      • 11.3.1 Eisai Company Details

      • 11.3.2 Eisai Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Eisai Lower GI Series Main Business and Markets Served

      • 11.3.4 Eisai Lower GI Series Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Novadaq

      • 11.4.1 Novadaq Company Details

      • 11.4.2 Novadaq Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Novadaq Lower GI Series Main Business and Markets Served

      • 11.4.4 Novadaq Lower GI Series Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Astrazeneca

      • 11.5.1 Astrazeneca Company Details

      • 11.5.2 Astrazeneca Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Astrazeneca Lower GI Series Main Business and Markets Served

      • 11.5.4 Astrazeneca Lower GI Series Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Cadila Pharmaceuticals

      • 11.6.1 Cadila Pharmaceuticals Company Details

      • 11.6.2 Cadila Pharmaceuticals Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Cadila Pharmaceuticals Lower GI Series Main Business and Markets Served

      • 11.6.4 Cadila Pharmaceuticals Lower GI Series Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Peacehealth

      • 11.7.1 Peacehealth Company Details

      • 11.7.2 Peacehealth Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Peacehealth Lower GI Series Main Business and Markets Served

      • 11.7.4 Peacehealth Lower GI Series Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Lower GI Series Market Outlook by Types and Applications to 2028

    • 12.1 Global Lower GI Series Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Double-Contrast Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Single-Contrast Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Lower GI Series Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Colon Polyps Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Strictures Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Lower GI Series Market Analysis and Outlook to 2028

    • 13.1 Global Lower GI Series Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Lower GI Series Consumption Forecast (2022-2028)

      • 13.2.2 Canada Lower GI Series Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Lower GI Series Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.2 UK Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.3 Spain Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.5 France Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.6 Italy Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.8 Finland Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.9 Norway Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.11 Poland Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.12 Russia Lower GI Series Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Lower GI Series Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.2 Japan Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.3 India Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Lower GI Series Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Lower GI Series Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.3 Chile Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.6 Peru Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Lower GI Series Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Lower GI Series Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Lower GI Series Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Lower GI Series Consumption Forecast (2022-2028)

      • 13.6.3 Oman Lower GI Series Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Lower GI Series Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Lower GI Series Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Lower GI Series Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Lower GI Series Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Lower GI Series Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Lower GI Series Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Lower GI Series Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Lower GI Series Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Lower GI Series Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Lower GI Series

    • Figure of Lower GI Series Picture

    • Table Global Lower GI Series Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Lower GI Series Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Double-Contrast Consumption and Growth Rate (2017-2022)

    • Figure Global Single-Contrast Consumption and Growth Rate (2017-2022)

    • Figure Global Gastroenteritis Consumption and Growth Rate (2017-2022)

    • Figure Global Colon Polyps Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Strictures Crohn's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lower GI Series Consumption by Country (2017-2022)

    • Table North America Lower GI Series Consumption by Country (2017-2022)

    • Figure United States Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Canada Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Mexico Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table Europe Lower GI Series Consumption by Country (2017-2022)

    • Figure Germany Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure UK Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Spain Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Belgium Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure France Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Italy Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Denmark Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Finland Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Norway Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Sweden Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Poland Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Russia Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Turkey Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table APAC Lower GI Series Consumption by Country (2017-2022)

    • Figure China Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Japan Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure India Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure South Korea Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Thailand Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Singapore Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Philippines Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table South America Lower GI Series Consumption by Country (2017-2022)

    • Figure Brazil Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Colombia Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Chile Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Argentina Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Peru Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table GCC Lower GI Series Consumption by Country (2017-2022)

    • Figure Bahrain Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Oman Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Qatar Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table Africa Lower GI Series Consumption by Country (2017-2022)

    • Figure Nigeria Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure South Africa Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Egypt Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure Algeria Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table Oceania Lower GI Series Consumption by Country (2017-2022)

    • Figure Australia Lower GI Series Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Lower GI Series Consumption and Growth Rate (2017-2022)

    • Table Ironwood Pharmaceuticals Company Details

    • Table Ironwood Pharmaceuticals Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceuticals Lower GI Series Main Business and Markets Served

    • Table Ironwood Pharmaceuticals Lower GI Series Product Portfolio

    • Table Purdue Pharma Company Details

    • Table Purdue Pharma Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma Lower GI Series Main Business and Markets Served

    • Table Purdue Pharma Lower GI Series Product Portfolio

    • Table Eisai Company Details

    • Table Eisai Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Lower GI Series Main Business and Markets Served

    • Table Eisai Lower GI Series Product Portfolio

    • Table Novadaq Company Details

    • Table Novadaq Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novadaq Lower GI Series Main Business and Markets Served

    • Table Novadaq Lower GI Series Product Portfolio

    • Table Astrazeneca Company Details

    • Table Astrazeneca Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Lower GI Series Main Business and Markets Served

    • Table Astrazeneca Lower GI Series Product Portfolio

    • Table Cadila Pharmaceuticals Company Details

    • Table Cadila Pharmaceuticals Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Pharmaceuticals Lower GI Series Main Business and Markets Served

    • Table Cadila Pharmaceuticals Lower GI Series Product Portfolio

    • Table Peacehealth Company Details

    • Table Peacehealth Lower GI Series Sales, Price, Value and Gross Profit (2017-2022)

    • Table Peacehealth Lower GI Series Main Business and Markets Served

    • Table Peacehealth Lower GI Series Product Portfolio

    • Figure Global Double-Contrast Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Single-Contrast Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colon Polyps Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Strictures Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lower GI Series Consumption Forecast by Country (2022-2028)

    • Table North America Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure United States Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure Germany Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure China Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure Brazil Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Lower GI Series Consumption Forecast by Country (2022-2028)

    • Figure Australia Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Lower GI Series Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.